BR9813222A - Agente e alimento funcional antitensão - Google Patents

Agente e alimento funcional antitensão

Info

Publication number
BR9813222A
BR9813222A BR9813222-9A BR9813222A BR9813222A BR 9813222 A BR9813222 A BR 9813222A BR 9813222 A BR9813222 A BR 9813222A BR 9813222 A BR9813222 A BR 9813222A
Authority
BR
Brazil
Prior art keywords
functional food
pro
tension
agent
tension agent
Prior art date
Application number
BR9813222-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Akihiro Masuyama
Toshiaki Takano
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of BR9813222A publication Critical patent/BR9813222A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
BR9813222-9A 1997-09-26 1998-02-05 Agente e alimento funcional antitensão BR9813222A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
PCT/JP1998/000480 WO1999016461A1 (fr) 1997-09-26 1998-02-05 Agents antistress et aliments fonctionnels

Publications (1)

Publication Number Publication Date
BR9813222A true BR9813222A (pt) 2000-08-29

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813222-9A BR9813222A (pt) 1997-09-26 1998-02-05 Agente e alimento funcional antitensão

Country Status (23)

Country Link
US (1) US6410685B1 (enExample)
EP (1) EP1018341B1 (enExample)
JP (1) JP4727770B2 (enExample)
KR (2) KR100383492B1 (enExample)
CN (1) CN1198641C (enExample)
AT (1) ATE264687T1 (enExample)
AU (1) AU728565B2 (enExample)
BG (1) BG64692B1 (enExample)
BR (1) BR9813222A (enExample)
CA (1) CA2303810C (enExample)
CZ (1) CZ298848B6 (enExample)
DE (1) DE69823369T2 (enExample)
DK (1) DK1018341T3 (enExample)
ES (1) ES2219868T3 (enExample)
HU (1) HUP0004617A3 (enExample)
ID (1) ID25635A (enExample)
IN (1) IN190794B (enExample)
PL (1) PL192873B1 (enExample)
PT (1) PT1018341E (enExample)
SK (1) SK285148B6 (enExample)
TR (1) TR200000863T2 (enExample)
TW (1) TWI231213B (enExample)
WO (1) WO1999016461A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105040A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
JPWO2004026296A1 (ja) * 2002-09-18 2006-01-12 味の素株式会社 抗ストレス性疾患組成物
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
TWI411441B (zh) 2003-03-18 2013-10-11 Suntory Holdings Ltd 血管收縮素轉化酶抑制性肽類
MXPA05011784A (es) 2003-05-05 2006-01-26 Unilever Nv Producto de caseina hidrolizada que comprende tripeptidos isoleucina-prolina-prolina y/o valina-prolina-prolina.
WO2005096847A1 (en) * 2004-03-19 2005-10-20 Campina Nederland Holding B.V. Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained
WO2006005757A2 (en) * 2004-07-12 2006-01-19 Dsm Ip Assets B.V. Blood pressure lowering oligopeptides
AU2006217901B2 (en) * 2005-02-24 2011-09-29 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
CN101272693B (zh) * 2005-07-26 2012-08-01 卡尔皮斯株式会社 发酵乳的制造方法和发酵乳饮料食品
US20100166859A1 (en) * 2006-01-16 2010-07-01 Luppo Edens Novel nutraceutical compositions and use thereof
EP2040732A4 (en) * 2006-05-15 2009-08-19 Valio Ltd NEW USE OF THERAPEUTICALLY USEFUL PEPTIDES
RU2304444C1 (ru) * 2006-05-23 2007-08-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
CN101909645A (zh) * 2007-11-14 2010-12-08 帝斯曼知识产权资产管理有限公司 包含ipp和/或vpp的降血压组合
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) * 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
WO2017057319A1 (ja) * 2015-09-30 2017-04-06 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
IE70080B1 (en) * 1989-02-16 1996-10-30 Sankyo Co Peptides having renin inhibitory activity their preparation and use
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
SK4362000A3 (en) 2001-03-12
CZ298848B6 (cs) 2008-02-27
CZ20001083A3 (cs) 2001-01-17
TR200000863T2 (tr) 2000-11-21
KR100379819B1 (ko) 2003-04-14
ID25635A (id) 2000-10-19
HUP0004617A3 (en) 2001-11-28
CA2303810A1 (en) 1999-04-08
EP1018341A1 (en) 2000-07-12
DE69823369D1 (de) 2004-05-27
CN1279614A (zh) 2001-01-10
EP1018341B1 (en) 2004-04-21
KR100383492B1 (ko) 2003-05-12
KR20010024277A (ko) 2001-03-26
PL339348A1 (en) 2000-12-18
CN1198641C (zh) 2005-04-27
ES2219868T3 (es) 2004-12-01
JP4727770B2 (ja) 2011-07-20
WO1999016461A1 (fr) 1999-04-08
CA2303810C (en) 2007-03-27
AU5780198A (en) 1999-04-23
AU728565B2 (en) 2001-01-11
BG104381A (en) 2001-02-28
JPH11100328A (ja) 1999-04-13
IN190794B (enExample) 2003-08-23
KR20030005137A (ko) 2003-01-15
BG64692B1 (bg) 2005-12-30
DK1018341T3 (da) 2004-07-26
TWI231213B (en) 2005-04-21
US6410685B1 (en) 2002-06-25
SK285148B6 (sk) 2006-07-07
DE69823369T2 (de) 2005-05-04
PT1018341E (pt) 2004-08-31
PL192873B1 (pl) 2006-12-29
EP1018341A4 (en) 2002-08-28
ATE264687T1 (de) 2004-05-15
HUP0004617A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
CA2303810A1 (en) Antistress agents and functional foods
BR9914185A (pt) Confeitaria hidrocolóide
ES2158494T3 (es) Caramelos que contienen un edulcorante.
BR9711126A (pt) Medicamentos antiestresse e alimentos funcionais com efeitos antiestresse.
BR0112770A (pt) Agentes herbicidas
BR9814147A (pt) "derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf"
BR0306214A (pt) Composto de 4-oxoquinolina e uso deste como inibidor de integrase de hiv
EP1411959A4 (en) CURCUMINOID COMPOSITIONS WITH SYNERGISTIC INHIBITION OF THE EXPRESSION AND / OR ACTIVITY OF CYCLOOXYGENASE-2
CA2241894A1 (fr) Utilisation de l'octoxyglycerine dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et/ou de l'acne
EP0935963A3 (en) The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders
WO2000015205A3 (en) Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
WO2003020273A3 (en) Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use
BR9912179A (pt) Composição neuroprotetora para a prevenção e/ou tratamento de alterações nervosas e do comportamento devido a estados de ansiedade ou depressão
BR0006045A (pt) Composição que compreende uma carnitina e glutationa, útil para aumentar a absorção de glutationa e para sinergizar seus efeitos
BR0214299A (pt) Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo
BR9507203A (pt) Derivado de oxima e bactericida que contém o mesmo como ingredientes ativo
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
BR9800766A (pt) Preparado de combinação para a aplicação na demência.
TR200101109T2 (tr) Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu
TR200101344T2 (tr) Propionil L-karnitinden ve bir flavonoid'den oluşan antioksidan bileşim
DK1049480T3 (da) Antiviralt middel af planteoprindelse
TR200102583T2 (tr) Alt idrar yolları semptomlarının tedavisine yönelik farmasötik bileşim.
ATE258063T1 (de) Selektive mmp inhibitoren mit verringerten nebenwirkungen

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, OPINO PELO INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM O ART. 13 DA LPI 9279/96).

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/55 (2006.01), A23L 33/18 (2016.0